2025 International Congress » Parkinson's Disease: Epidemiology, Phenomenology, Clinical Assessment, Rating Scales

1-Year Outcomes for MDS-UPDRS Part I-IV and Clinical Impressions: Insights from a Large Real-World Prospective Study on de novo STN-DBS in Parkinson’s Disease

S. Groppa, L. Lopez-Manzanares, A. Schnitzler, S. Chen, C. Salazar, Y. Ram, M. Chung, A. Gharabaghi (Homburg, Germany)

A 6-Year Longitudinal Analysis from the Parkinson’s Progression Markers Initiative on Non-Motor Symptom Severity and Progression in GBA1-associated vs. sporadic Parkinson’s Disease

M. Fonseca, D. Ramos, V. Di Foggia, R. Costa, J. Holenz, D. Simon, T. Marker Initiative (Coronado, Portugal)

A Comparative Analysis of Water-Based versus Land-Based Exercise Interventions for Improving Quality of Life in Parkinson’s Disease: A Systematic Review

S. A. Hassan, A. Abdelsalhin, M. Mustafa, N. Elmestkawy, O. Hafez, N. Abdeltawab, M. M. Elsayed (Giza, Egypt)

A multi-center, randomized, controlled study of the add-on effect of selegiline or zonisamide to L-dopa/DCI therapy in Parkinson’s disease (DATSZ-PD study)

M. Takahashi, J. Koh, T. Shimokawa, Y. Kajimoto, T. Takeshima, H. Ito (Hirakata, Osaka, Japan)

A personalized gait signature assay in Parkinson’s disease

H. Babcock, J. Stephen, V. Vanderhorst (Boston, USA)

A Registry for Sleep and Circadian Health Quality in Parkinson’s Disease (ReSCQu-PD)

J. Cohen (Jacksonville, USA)

A shortened MDS-UPDRS Patient-based item bank increases sensitivity for predicting dopaminergic therapy initiation: A Longitudinal IRT Analysis in early PD

S. Luo, L. Yu, G. Stebbins, T. Mestre, C. Goetz (Durham, USA)

A Study of Delayed Specialist Consultation in Parkinson’s Disease Patients in Uzbekistan

L. Kenjaeva, B. Mukhammedaminov, N. Aripova, Y. Nishonova, G. Kendjaeva (Tashkent, Uzbekistan)

A Tailored Approach to Parkinson’s Disease: The Influence of Hormonal Status in Women

B. Perraud, I. Beaulieu-Boire (Sherbrooke, Canada)

Accuracy of the Tanner’s Questionnaire and the REM Sleep Behavior Disorder Single-Question Screen as Screening Tools for Parkinson’s Disease in a Brazilian Cohort

G. Bolner, G. Magalhães Pereira, N. Medeiros Soares, C. Cenci Sangali, D. Dos Santos, T. de Carvalho, C. Mello Rieder, A. Schumacher Schuh (Porto Alegre, Brazil)

Adaptive Deep Brain Stimulation Algorithmic Performance Evaluation Through Symptom Driven Metrics

K. Balagula, J. Yao, M. Shcherbakova, A. Hahn, P. Starr, S. Little (San Francisco, USA)

Advancing MDS Guidelines for Electronic Clinical Outcome Assessments: Best Practices for Validation and Implementation

R. Fuller, M. Skorvanek, M. Monje, M. Tosin, S. Ali, A. Lofald, A. Sanchez Ferro, T. Mestre (Princeton, USA)

Age-related Trends in Amyloid Positivity in Parkinson’s Disease without Dementia

K. Hatano, M. Kameyama, M. Kurihara, K. Ohse, R. Goto, R. Ihara, M. Higashihara, R. Sengoku, Y. Nishina, K. Kanemaru, Y. Saito, S. Murayama, A. Iwata (Tokyo, Japan)

Alterations in Gait Initiation of subjects with Parkinson’s Disease: a comparative study with matched healthy controls

D. Bonacina, D. Tosatto, A. Arrighetti, C. Perin, C. Alessandro, D. Piscitelli (Storrs, USA)

Analysis of statistical data on patients with Parkinson’s disease.

R. Matmurodov, S. Jumanazarova, E. Abduqodirov, M. Abdullayeva (Tashkent, Uzbekistan)

Anti-diabetic Drug Use and the Risk of Parkinson’s Disease among Older Adults in Japan: the LIFE Study

Y. Kimura, S. Ge, T. Kitamura, L. Zha, Y. Shimomura, M. Komatsu, Y. Gon, S. Komukai, M. Maeda, K. Kiyohara, H. Mochizuki, H. Fukuda (Suita, Japan)

Apathy and Risk of Parkinson’s Disease: A Population-Based Cohort Study

A. Otaiku (London, United Kingdom)

Assessing the Impact of Interprofessional Education on Collaborative Practice in Neurorehabilitation for Parkinson’s Disease: A Systematic Review

Y. Hamdi, S. Elsenbawy, G. Abozeid, D. W. Ismail, H. Elshazly, M. Elsayed (Giza, Egypt)

Assessment of cognitive impairment in Parkinson’s disease in Bangladeshi patients in Dhaka as part of the London-Dhaka Parkinson’s Cognition Study

A. Haque, K. Dey, T. Zannat, A. Zirra, E. Camboe, S. Waters, D. Mair, T. Haque, C. Marshall, R. Weil, N. Mukadam, A. Noyce, A. Habib (Dhaka, Bangladesh)

Assessment of the Applicability of the King and PD-PCS Scales in Patients with Parkinson’s Disease and Chronic Pain: a Pilot Study

J. Queiroz, P. Matos, A. Ferreira Gomes, I. Santos, F. Rolim, D. de Andrade, F. Carvalho (Fortaleza, Brazil)

Association between cognitive adverse effects of anticholinergic medication and development of long-term dementia in Parkinson’s disease

SH. Ha, BR. Jin, SY. Kim, SM. Lee, JH. Shin, HJ. Kim (Seoul, Republic of Korea)

Association Between Depression and Sleep Disorders in Parkinson’s Disease

J. Jiang, W. Wu, M. Mao (Suzhou, China)

Association Between Pesticide Exposure and Clinical Outcomes in Parkinson’s Disease: A Propensity-Matched Cohort Study

C. Cerquera-Cleves, G. Pinilla-Monsalve, M. Blais, M. Cressati, C. Normandeau, C. Degroot, I. Kathol, S. Bogard, A. Bendas, R. Camicioli, Z. Gan-Or, DA. Grimes, K. Schoffer, LV. Kalia, PA. Macdonald, MJ. Mckeown, D. Martino, J. Miyasaki, M. Schlossmacher, AJ. Stoessl, A. Strafella, E. Fon, O. Monchi, N. Dupré, F. Cicchetti (Québec, Canada)

Association Between Trait Impulsivity and Freezing of Gait in People with Parkinson’s Disease

H. Cavalcanti, D. Dos Santos, G. Valença, E. Pinto, J. Oliveira-Filho, L. de Almeida (Cachoeira, Brazil)

Automatic quantification of motor symptoms including freezing of gait in Parkinson’s disease through motion capture

W. Sako, M. Osawa, T. Iguchi, T. Hara, H. Haginiwa, S. Haji, N. Hattori (Bunkyo, Japan)

Bias in Pharmacoepidemiological Studies of Parkinson’s Disease Prescribing Patterns: A Systematic Review

K. Orayj (Abha, Saudi Arabia)

Biological Characteristics of Individuals with RBD: A Multicenter Prospective Longitudinal Cohort

J. Feuerstein, E. Brown, L. Chahine, C. Gochanour, D. Lafontant, M. Marshall, T. Simuni, D. Weintraub (Aurora, USA)

Center of Mass and Center of Pressure interactions during Gait in people with Parkinson’s Disease

D. Tosatto, D. Bonacina, F. D'Andrea, C. Perin, C. Alessandro, D. Piscitelli (Milano, Italy)

Characteristics and Trends of Parkinson’s Disease Patients Receiving Deep Brain Stimulation: Insights From a US All-Payer Health Administrative Claims Database

W. Zhang, M. Bharadwaz, A. Gabriel, J. Weber, M. Frick, A. Yaldo, C. Gøtzsche, T. Machewitz, J. Lott (Whippany, USA)

Clinical analysis of sarcopenia prevalence and its influencing factors in patients with Parkinson’s disease

R. Morimoto, K. Kitagawa, K. Todo, M. Iijima (Tokyo, Japan)

Clinical Characteristics of Parkinsons Disease and their Role in Differential Diagnosis

M. Ganieva, L. Tolibova (Dushanbe, Tajikistan)

Clinical Features of Juvenile Parkinson Disease: a Comparative Study with Early-Onset Parkinson Disease

L. Malfer, C. Piat, A. Mullan, K. Coffman, R. Savica (Rochester, USA)

Clinical Manifestations and Rate of Progression of Parkinsons Disease in Different Regions

M. Qurbonova, M. Isrofilov (Dushanbe, Tajikistan)

Co-occurrence of Parkinson Disease and Myasthenia Gravis in Hospitalized Patients: A Nationwide Analysis

S. Abdul-Ghani, J. Miles (Honolulu, USA)

Comparison of clinical symptoms between young-onset and elderly-onset in patient with early Parkinson’s disease

M. Iijima, R. Morimoto, K. Suzuki, S. Nogawa, Y. Okuma (Tokyo, Japan)

Correlational Analysis between Anxiety and Self-perception of Health in Patients with and without Idiopathic Parkinson’s Disease without Dementia.

S. Ospina Otalvaro, C. Alberto Hurtado-González, J. Felipe Ayala-Rico, P. Andrea Gutiérrez-Leni, A. Lucumi-Moreno, S. Cárdenas-Zuñiga, M. Cañas-Lucendo, D. Reyes-Torres, S. Ordoñez-Cure, A. Cubides-Munévar, E. Muñoz-Alvarez (Cali, Colombia)

Critical appraisal of MDS Criteria for diagnosing PD

S. Fox, . , . (Toronto, Canada)

Decline in Motor Function and Cognitive Abilities in GBA PD Compared to Idiopathic PD (iPD)

B. Mangal, C. Edgar, O. Siddiqui, M. Facheris, M. Hagey, D. Weintraub, T. Simuni (Chicago, USA)

Demographic Characteristics of Women with Primary Parkinsonism

E. Tharp, J. Martinez-Lemus, J. Suescun, M. Schiess (Houston, USA)

Depressive Symptomatology in a Group of Patients Diagnosed with Idiopathic Parkinson’s Disease Without Dementia. Descriptive Study of the ESDEPARK Scale.

P. Andrea Gutiérrez-Lenis, C. Alberto Hurtado-González, J. Felipe Ayala-Rico, S. Ospina-Otalvaro, A. Lucumi Moreno, M. Cañas-Lucendo, D. Reyes-Torres, L. Maria Villegas-Trujillo, S. Ordoñez-Cure, M. Alejandra Vásquez-Martínez (Zaragoza, Spain)

Developing Competency-Based Training Modules for Health Professionals in Parkinson’s Disease Management: A Review of Current Practices and Future Needs

M. Alfeky, M. Alomari, N. Bekhit, F. Sakr, A. Hafez, O. Awadalla, M. M. Elsayed (Giza, Egypt)

Developing Disease-duration Specific Percentiles for Prospective Subtyping of the Diffuse Malignant Parkinson’s Disease: A PPMI-based study

A. Negida, M. Barrett, SM. Fereshtehnejad, B. Berman, N. Mukhopadhyay (Toronto, Canada)

Development of a non-contact monitoring technology for the motor symptoms of Parkinson’s disease using Wi-Fi sensing

G. Oyama, K. Seo, M. Hirayama, T. Kadotani, R. Hosaka, S. Fujita, S. Fujii, M. Marumo, N. Hattori (Saitama, Japan)

Distinguishing Functional and Essential Tremor from Tremor in Parkinson’s Disease using an objective comprehensive Motor Symptom Assessment Device

D. Bramwell, C. Papasavvas, M. Walter, A. Dimelow, A. Deutschländer, R. Zietsma (Newcastle upon Tyne, United Kingdom)

Early Indicators of Alpha-synuclein Aggregation: Can Autonomic and Cognitive Markers Predict Prodromal Parkinson’s Disease?

B. Kansu, C. Mattjie, R. Ravazio, M. Patyjewicz, A. Noyce, C. Simonet (London, United Kingdom)

Early-Onset Parkinson’s Disease in Active-Duty Service Members

V. Nguyen, J. Jacobson, C. Hernandez-Zegada, M. Salas, W. Hoffman (San Antonio, USA)

Educational Strategies for Enhancing Caregiver Knowledge and Capacities in Parkinson’s Disease Management: A Comprehensive Review

S. A. Hassan, S. Abozeid, Y. M.HUSSEINY, H. Abdelbar, S. Elrobeigi, M. M. Elsayed (Giza, Egypt)

Effect of Virtual Rehabilitation Therapy on Patients with Parkinson’s Disease: A Systematic Review and Meta-Analysis

F. Luna-Rangel, B. Gonzalez-Bedolla, C. Armengol-Garcia, D. Martinez-Ramirez (Monterrey, Mexico)

Effects of transmembrane protein 106B genetic variations on disease progression in Parkinson’s disease

Y. Fan, W. Zhao, X. Liang, Y. Sun, J. Wang (Shanghai, China)

Efficacy of Rifaximin as an Adjunct Treatment for Levodopa induced dyskinesia: Preliminary Results

K. Salinas-Barboza, J. Altamirano, L. Navarro-Roa, M. Rodriguez-Violante (Ciudad de México, Mexico)

Epidemiology of Parkinson’s disease in Southern Brazil: Age- and Sex-Specific Findings from the PROBE-PD Study

G. Pereira, N. Soares, C. Sangali, D. Teixeira-Dos-Santos, G. Valença, B. Lopes, P. Brandão, C. Rieder, A. Schuh (Porto Alegre, Brazil)

Ethnicity in Parkinson’s Disease: A Brazilian Cross-sectional Study

J. Oliveira, G. Nunes, N. Dos Santos, F. Brito, J. Costa, E. Muricy, G. de Vasconcelos, S. Baran, R. Kauark (Salvador, Brazil)

Evaluating Inter-rater Variability in UPDRS Using IMU: A Comparison Between Beginner and Experienced Specialists

TC. Fang, PS. Lu, YJ. Guo, JA. Huang, LW. Ko (Taichung, Taiwan)

Evaluating the Efficacy of Home-Based Exercise Interventions for Individuals with Mild to Moderate Parkinson’s Disease: A Systematic Review

M. M. Elsayed, M. Alomari, N. Abdeltawab, O. Hafez, N. Elmestkawy, M. Mustafa, A. Abdelsalhin, S. A. Hassan (Mansoura, Egypt)

Evaluation of Effects of Levodopa and Subthalamic Nucleus Stimulation (STN-DBS) on Gait using Quantified Timed Up and Go Test in People with Parkinson’s Disease (PD)

F. Ruggieri, E. Reynolds, C. O'Keeffe, J. Inocentes, M. Kelly, E. Donlon, M. Garvey, N. Austin, C. Fearon, C. Moran, R. Walsh (Dublin, Ireland)

Examining the Influence of Task Complexity on Dual Task Performance in Parkinson’s disease.

S. Conklin, P. Hill, L. Schwarz, YF. Chiu, J. Longhurst (Saint Louis, USA)

Exploratory Longitudinal Analysis of Lifestyle and Parkinson’s Disease Symptoms

N. Meier, O. Di Martino, I. Chaturvedi (Irvine, USA)

Exploring expectation bias in Parkinson’s disease clinical trials by comparing placebo arm progression on MDS-UPDRS to a natural history dataset

M. Potashman, L. Powell, B. Rogula, F. Nagase, C. de Brun, V. Coric, J. Dubow, L. Rosenthal, G. L'Italien (New Haven, USA)

Facilitators and Barriers to Exercise Program Implementation in Parkinson’s Disease Rehabilitation: A Comprehensive Review Using the Consolidated Framework for Implementation Research

M. M. Elsayed, N. Bekhit, F. Sakr, A. Hafez, O. Awadalla, M. Mohamed, A. Nagah (Mansoura, Egypt)

Falls in Parkinson Disease, Videonystagmography and Fear of Falls – an Exploratory Study.

I. Monteiro, M. Salmito, K. Aguiar, F. Rolim, M. Rela, A. Ferreira Gomes, F. Carvalho (Fortaleza, Brazil)

Family History of Parkinson’s Disease in Patients with Essential Tremor and in Patients with Parkinson’s Disease and Its Association with Different Phenotypes.

R. Sanjinez, J. Bestoso (Buenos Aires, Argentina)

Finding Prodromal Parkinson’s Disease with the Movement Disorder Society’s Prodromal Calculator and Electronic Health Records

J. Heller, K. Fitzgerald (Baltimore, USA)

Food-Related Predictors of Parkinson Progression

L. Mischley, J. Farahnik, M. Murawska (Kenmore, USA)

Force Estimation as a Method to Assess Proprioception in Parkinson’s Disease Patients

M. Wilken, G. Bianchi, M. Martínez Sucre, C. Cruz Molina, G. Noel, D. Andres, M. Merello (Buenos Aires, Argentina)

Frequency of Falls in the Parkinson’s Progression Markers Initiative

J. Vizcarra, D. Lafontant, A. Siderowf (Philadelphia, USA)

Frequency of Overweight and Obesity in a Cohort of Parkinson’s Disease Patients

K. Aguiar, I. Monteiro, A. Ferreira Gomes, I. Santos, F. Rolim, A. Lima Verde, A. Carioca, F. Carvalho (Fortaleza, Brazil)

Gender-Based Differences in Parkinson’s Disease Hospitalization: A Nationwide and Single Center Study

Z. Xu, N. Bujala, A. Jain, E. Spirollari, A. Sacknovitz, A. Jiang, F. Al-Mufti, R. Fekete (New York, USA)

Global Cognition Influences Non-Tremor Motor Decline in Parkinson’s Disease

M. Gibbs, A. D'Souza, C. Sotirakis, T. Crawford, J. Fitzgerald, C. Antoniades (Oxford, United Kingdom)

Health Disparity in Rural Southern California

A. Maleki, M. Tar, D. Tar (moreno valley, USA)

Helicobacter Pylori Infection, Peptic Ulcer, Gastritis and Risk of Parkinson´s Disease: a Nationwide Matched Cohort Study

S. Licaj, A. Ploner, A. Szwajda, S. Hägg, F. Fang, J. Ludvigsson, K. Wirdefeldt (Solna, Sweden)

Heterogeneity of the First Clinical Manifestations Reported in Patients with Early- and Late-Onset Parkinson’s Disease.

J. Trejo-Ayala, H. Trujillo-Guerra, J. Sánchez-Garza, D. Ortiz-Zacarías, S. Castillo-Torres, B. Chávez-Luévanos, I. Estrada-Bellmann (Monterrey, Mexico)

How Feasible and Valuable is Home Lying Standing Blood Pressure Monitoring in People with Parkinsonism?

K. Lloyd, S. Haworth, M. Nogradi, C. Glover, EJ. Henderson (Bristol, United Kingdom)

Impact of Genetically Defined Ancestry on Progression of Idiopathic Parkinson’s Disease.

J. Frost, S. Gray-Rodriguez, L. Wu, M. Lawton, Y. Ben-Shlomo, M. Hu, D. Grosset, R. Real, H. Morris (London, United Kingdom)

Impact of Innovative Physiotherapy Interventions on Motor Function and Quality of Life in Patients with Parkinson’s Disease and Movement Disorders

E. Nakanwagi, G. Wangolo (KAMPALA, Uganda)

Impact of parkinson’s disease on work disability: a cross-sectional study

S. Secades, C. Martin (Madrid, Spain)

Impact of Skin Biopsy Detection of Phosphorylated Alpha-Synuclein and its Distribution Patterns on the Diagnosis of Synucleinopathies

M. Chen, M. Christie (Houston, USA)

Improving Diagnosis of Dementia in Parkinson’s Disease: PDCogniCare Australian Program

N. Dissanayaka, D. Pourzinal, E. Mccann, E. Lobo, D. Brooks, D. Sriram, T. Au, L. Mitchell, N. Pachana, S. Naismith, A. Broome, A. Lehn, A. Kelder, J. Liddle, J. King, R. Marsh, S. Robertson, K. Shrubsole, H. Tinson, M. Verreynne, B. Wood, P. Worthy, J. Yang, P. Nestor, M. Chatfield, S. Keramat, E. Tan, T. Piccinini, E. Beattie, G. Byrne, D. Spooner, J. O'Sullivan (Camperdown, Australia)

Incidence and Associated Factors for Phenoconversion of Parkinson’s Disease in the Chinese Community Older Adults with LRRK2 G2385R and R1628P Variants

J. Liu, T. Mi, Z. Gu, Y. Li, M. Cao, Z. Ren, H. Zhang, M. Chen, J. Chen, L. Ma, X. Xu, C. Han, L. Zhang, J. An, P. Chan (Beijing, China)

Increase eye blink rate as a motor fluctuation in levodopa-Induced dyskinesia in parkinson’s disease a forgotten indicator of motor fluctuations a case report

K. Salinas-Barboza, C. Alfaro-Tapia, JM. Altamirano (Mexico, Mexico)

Integrating the Collaborative Care Mental Health Model into Virtual Parkinson’s Disease Care

E. Ferluga, E. Anderson, N. Flanagan, D. Geraldi-Samara, J. Riser, K. Brendle (Chicago, USA)

Investigating the use of Wearable Technologies as a Digital Biomarker for GBA1-Parkinson’s Disease

N. Loefflad, M. Toffoli, E. Menozzi, A. Schapira (London, United Kingdom)

Knowledge, Perception and Access to Care for Parkinson’s Disease in Two Selected Local Government Areas in Lagos State, Southwestern Nigeria.

O. Ibode, A. Ogunyemi, O. Ojo, R. Walker, N. Okubadejo (Lagos, Nigeria)

Levodopa response in pathology-confirmed Parkinson’s Disease, Multiple System Atrophy and Progressive Supranuclear Palsy

V. Arca, J. Jurkeviciene, S. Wrigley, P. Cullinane, J. Parmera, Z. Jaunmuktane, T. Warner, E. de Pablo-Fernandez (London, United Kingdom)

Life Course Sleep Duration Trajectories and Risk and Age at Onset of Parkinson’s Disease

Y. Fang, R. Hardy, K. Yaffe, S. Little, C. Tanner, Y. Leng (San Francisco, USA)

Long-Term Effects of Telerehabilitation on Functional Mobility and Quality of Life in Parkinson’s Disease: A Systematic Review

A. Elsayed, D. W. Ismail, H. Elshazly, Y. M.HUSSEINY, S. Elrobeigi, Y. Hamdi, M. M. Elsayed (Mansoura, Egypt)

Low Nutritional and Metabolic Abnormalities Predict the Incidence of Parkinson Diseases: A Large Prospective Cohort Study

J. Fu, X. Chen, H. Shang (Chengdu, China)

Lung Function and the Risk of Parkinson’s Disease: A Population-based Cohort Study

JY. Liu, SC. Wang, XT. Zheng, SR. Zhang, QR. Jiang, CY. Li, HF. Shang (Chengdu, Sichuan, China)

Metabolic dysfunction-associated steatotic liver disease, body mass index, and risk of Parkinson’s disease

SJ. Chung, TS. Lim, J. Jeon, JK. Kim, J. Kim, PH. Lee (Seoul, Republic of Korea)

Morbidity and Mortality Associated with Aspiration Pneumonia: Nationwide Trends in Inpatient Therapy Utilization in Parkinson’s Disease Hospitalization

T. Mehta, H. Kamo, R. Burke, M. Rem, M. Okun, C. Hess (Gainesville, USA)

Mortality Trends Associated with Parkinson’s Disease with Diabetes Mellitus in the United States (1999-2020)

T. Patel, R. Khan, M. Athar, S. Aleem, A. Khan, M. Altaf, A. Khan, M. Shahabi, B. Aslam, E. Zulfiqar, R. Millis, A. Awosika (Kingstown, Saint Vincent and the Grenadines)

Multidisciplinary Approaches to Palliative Care in Late-Stage Parkinson’s Disease: A Review of Educational Tools and Frameworks

M. Farghaly, H. Khabiry, O. Sabry, A. Nagah, O. Awadalla, M. Elsayed (Giza, Egypt)

Multimodal Dissection of GALC Variants Linking Olfactory Deficits to Cognitive Decline in Parkinson’s Disease

Y. Li, M. Zhong, J. Liu (shanghai, China)

Multimodal Sensing-Enabled Diagnosis and Assessment of Parkinson’s Disease via Biomolecule and Biomechanics Signals

M. Zhang, D. Chen, H. Cao (Xi'an, China)

Muscle Coactivation in subjects with Parkinson’s Disease: a Healthy-matched analysis of the Sub-Phases of Gait Cycle

D. Bonacina, D. Tosatto, M. Leonardi, C. Perin, C. Alessandro, D. Piscitelli (Milano, Italy)

Muscle Interactions during Gait in People with Parkinson’s Disease

D. Tosatto, D. Bonacina, F. Fumagalli, A. Alessandro, C. Perin, D. Piscitelli (Milano, Italy)

Nasal septum deviation correlates with asymmetry in Parkinson’s disease

J. Wang, J. Wang, F. Liu, C. Zuo, Y. Sun, J. Wu (Shanghai, China)

Negative Correlation between Apathy and Executive Functioning in Patients with Idiopathic Parkinson’s Disease without Dementia.

P. Andrea Gutiérrez-Lenis, C. Alberto Hurtado-González, J. Felipe Ayala-Rico, S. Ospinta-Otalvaro, A. Lucumi-Moreno, M. Cañas-Lucendo, D. Reyes-Torres, S. Ordoñez-Cure, A. Cubides-Munévar, A. Maria Valencia-Orjuela (Cali, Colombia)

Neurocognitive Functioning and Neurobehavioral Alterations in a Group of Patients Diagnosed with Idiopathic Parkinson’s Disease Without Dementia by Deep Brain Stimulation. Descriptive Study of the ESDEPARK Scale.

C. Alberto Hurtado-González, J. Felipe Ayala-Rico, S. Ospina-Otalvaro, P. Gutiérrez-Lenis, A. Lucumi Moreno, M. Cañas-Lucendo, D. Reyes-Torres, L. Villegas-Trujillo, S. Ordoñez-Cure, K. Rivera-Quintero (Cali, Colombia)

Neurodegeneration Biomarkers: Correlation between Hippocampal Volume and Cognitive Performance by MoCA Test in Parkinson’s Disease

Y. Matuk Perez, E. Fernandez Calleja, D. Resendiz Gonzalez, JM. Esquivias Farías, S. Alcauter Solórzano, I. Zamorano-Rangel (Queretaro, Mexico)

Objective Monitoring of Axial symptoms in Parkinson’s Disease (OMNIA-PARK): the Study Protocol.

S. Gallo, M. Patera, G. Imbalzano, A. Zampogna, M. Ghislieri, U. Mosca, G. Amprimo, L. Borzì, S. Cerfoglio, MA. Gazzanti Pugliese, GL. Cerone, A. Botter, V. Cimolin, C. Claudia, L. Lopiano, F. Irrera, G. Olmo, A. Suppa, CA. Artusi (Pozzilli

Parkinson’s Disease and Cancer: A Meta-Analysis of Prevalence, Risk, and Specific Associations with Brain and Skin Cancers

H. Khelifa, A. R. Al-Ihribat, H. Smeda, A. Hendawy, A. Abunamoos (Oran, Algeria)

Parkinson’s Disease and Movement Disorders Mortality in Tunisia: Insights from the National Information System on Causes-of-Death (2020-2021)

M. Zribi, N. Zoghlami, S. Ben Maryem, M. Bennour, H. Aounallah-Skhiri (Tunis, Tunisia)

Parkinson’s Disease Diagnosed in a Patient with Anti-Musk Positive Myasthenia Gravis: Coincidence? – Case Report and Literature Review

J. Sánchez León, T. Luise Denicol, C. Matté Dagostini, R. de Castro, A. Hilbig, A. Hoppe, C. Mello Rieder (Porto Alegre, Brazil)

Parkinson’s Disease Epidemiology and Treatment Characteristics in Australia

M. Lubomski, A. Evans, R. Mackinnon, R. Rossiter, M. Falster, M. Kouhkamari, T. Suresh, A. Mikolaizak, J. Waern (St Leonards, Australia)

Parkinson’s disease GWAS-linked SNCA carriers show slower non-motor and cognitive progression

DX. Deng, LT. Tan, TEK. Tan (singapore, Singapore)

Parkinson’s Disease: Increased Presence of Neuropsychiatric Symptoms and Non-Motor Issues Drive Higher Medication Use and Costs

S. Horn, E. Vaou, A. Parab, S. Wang, X. Pan, C. Yan, M. Shah, J. Jimenez-Shahed (San Antonio, USA)

Parkinson’s disease overlapping with other neurodegeneration-case series with neuropathological description.

L. Milanowski, A. Salinska, A. Acewicz, M. Grzegorczyk, S. Tarka, S. Szlufik, T. Wierzba-Bobrowicz, D. Koziorowski (Warsaw, Poland)

People With Parkinson’s Disease and Care Partners Experience Costly Work Productivity Loss

I. Malaty, N. Boame, A. Parab, S. Wang, M. Shah, C. Yan, J. Jimenez-Shahed (Gainesville, USA)

Perceived Versus Actual Performance During Dual-Task Walking: Insights from Parkinson’s Disease

H. Johansson, B. Leavy (Stockholm, Sweden)

Pesticide Exposure and Parkinson’s Disease Motor Subtype

D. Thordarson, J. Bronstein, A. Keener, B. Ritz, K. Paul (Los Angeles, USA)

Planning for the Parkinson’s Pandemic: Care needs in Australian Residential Aged Care Facilities

J. Mcginley, S. Soh, Y. Mok, M. Callisaya, V. Mcconvey, M. Klaic, A. Vogel, D. Koye, D. Finkelstein, K. Bower (Parkville, Australia)

PREDIGT 2.0: A Self-Administered, Two-Step Screening Tool to Identify Individuals with Parkinson’s Disease

J. Li, K. Grimes, J. Saade, N. Mauri, J. Tomlinson, A. Frank, D. Manuel, B. Mollenhauer, M. Schlossmacher (Ottawa, Canada)

Prevalence and Clinical Characteristics of Parkinson’s disease in Rural Nepal: A Community-Based Cross-Sectional Study

A. Chandra, A. Chandra, S. Acharya (Kathmandu, Nepal)

Prevalence of Central Pain in Parkinson’s Disease: A Systematic Review and Meta-analysis

K. Vieira, L. Pereira, G. Trevisan (Santa Maria, Brazil)

Prevalence, demographic characteristics of Parkinson disease and associated comorbidities: An analysis of the Colombian Ministry of Health official registry

A. Rincon, C. Pantoja, J. Torres, C. Tamayo, D. Rosselli (Bogotá, Colombia)

Prodromal Parkinson’s Disease in Agent Orange Exposed US Vietnam Veterans

E. Uc, C. Weber, M. Lenz, J. Dawson (Iowa City, USA)

Profile and Predictors of Depression in Parkinson’s Disease Patients attending the Neurology Clinic at the University College Hospital, Ibadan, Nigeria.

A. Fagbemi, F. Taiwo, T. Sodimu (East Midlands, United Kingdom)

Quality of Life and Depression in Patients with and without Idiopathic Parkinson’s Disease without Dementia.

S. Ospina Otalvaro, C. Alberto Hurtado-González, J. Felipe Ayala-Rico, P. Andrea Gutiérrez-Leni, A. Lucumi-Moreno, S. Cárdenas-Zuñiga, M. Cañas-Lucendo, D. Reyes-Torres, S. Ordoñez-Cure, A. Cubides-Munévar, J. Marmolejo-Florez (Cali, Colombia)

Quality of Life Impact on Adults with Parkinson’s Disease Experiencing Morning Akinesia: Real-World Observational Findings

O. de Fabregues, K. Onuk, C. Yan, P. Kukreja, L. Bergmann, S. Colman, D. Falconer, J. Sarna, F. Ory-Magne, L. Defebvre, V. Fung (Barcelona, Spain)

Quality of Life of Parkinson’s Disease Patients in the Thai Population: A Cross-Sectional Analysis

C. Ounmuang, S. Rujirussawarawong, N. Limotai, S. Aungsumart, C. Kasemsuk (Bangkok, Thailand)

Real-life experience with continuous subcutaneous foslevodopa/foscarbidopa infusion in advanced stage of Parkinson’s disease at Villa Margherita

G. Nordera, N. Bonetto, F. Perini (Vicenza, Italy)

Redefining the Finger-tapping Test in Parkinsonian Patients: Finger to Crease Instead of Finger-to-tip

F. Akhoundi, Y. Bordelon, J. Leverenz, P. Oikonomou, I. Litvan (San Diego, USA)

Refining a Claims-Based Severity Rating Scale for Parkinson’s Disease Using Machine Learning

E. Krause, L. Kovalchick, A. Medhus, J. Theo, C. Truong, S. Park, X. Zhang, X. Jiang, T. Krause (Austin, USA)

Refining the International Parkinson and Movement Disorder Society Parkinson’s Disease Psychosis Rating Scale (MDS-PDPRS): Cognitive Interview Results from an International Study

M. Tosin, T. Mestre, G. Stebbins, G. Mangone, S. Videmsky, S. Ali, D. Aarsland, J. Goldman, T. Khoo, S. Lewis, P. Martinez-Martin, O. Ojo, J. Pagonabarraga, A. Schrag, D. Weintraub, C. Goetz (Chicago, USA)

Risk factors in a population with high prevalence of Parkinson’s disease in Chile

ME. Contreras Pinto, U. Hernandez Villarroel, N. Angel, F. Pancetti Vaccari, B. Soto, M. Ramirez, M. Vera Amoroso, J. Otero Olmos, G. Oneto Diaz, C. Morales (la serena, Chile)

Safety and tolerability of overnight switching from Eetacapone to Opicapone in fluctuating Parkinson’s disease: An open-label preliminary trial in Koreans

M. Park, J. An (Daegu, Republic of Korea)

Seasonal Variations in Emergency Department Admissions Among Parkinson’s Disease Patients: A North-South Comparative Analysis

S. Vallamkonda, C. Wiedner, B. Westbrook, N. Kakos, C. Hinds, M. Barnes, E. Madewell, M. Metcalf, R. Irvine, A. Menta, P. Bhaya, D. Petrosyan, A. Fajayan, O. Hofheinz, J. Passarelli, J. Kong, A. Benchouia, M. Muppirala, R. Bernal, J. Himali, A. Hohler, O. Vaou (San Antonio, USA)

Secular trends and survival of Parkinson’s disease and other forms of parkinsonism in the United Kingdom

S. Gandhi, K. Grosset, P. Iruthayaraj, R. Gravesande, L. Lee, C. Doyle, Y. Ben-Shlomo, D. Grosset (Glasgow, United Kingdom)

Sex differences in prodromal Parkinson’s disease (PD)

K. Atterling Brolin, S. Waters, H. Chohan, B. Huxford, S. Meyer, L. Smith, A. Shahid, A. Kuri, J. Bestwick, R. Benabderrazik, R. Lathey, E. Pablo Fernandez, L. Pérez-Carbonell, C. Simonet, A. Schrag, A. Noyce (London, United Kingdom)

Sex specific role of dyslipidemia and statin use in Parkinson’s disease pathogenesis

K. Tsutsumi, E. Shah, S. Isfahani (Orange, USA)

Single-Center Real-World Validation of Cognitive vs. Motor-Based Fall Prediction Models in Parkinson’s Disease

S. Anis, E. Zimmerman, H. Fernandez, A. Rosenfeldt, J. Alberts (Cleveland, USA)

Sleep Circadian Rhythms and Brain Disorders: A Large Prospective Cohort and Mendelian randomization Study

M. Zhong, J. Liu, Y. Li (shanghai, China)

Split tablet dosing of Levodopa/Carbidopa/Entacapone 100mg/25mg/200mg in treating Chinese patients with early Parkinson’s disease: a single-center, prospective cohort study

XY. Cheng, CJ. Mao, CF. Liu (Suzhou, China)

Study on individual differences in shoulder and hip joints during walking in patients with Parkinson’s disease

J. Ogawa, Y. Yamaguchi, K. Kakegawa, T. Matsuda, T. Kurayama (Ginza, Chuo-ku, Japan)

Subthalamic versus Pallidal Temporal Interference Stimulation in Parkinson’s Disease: A Pilot Study

J. Li, A. Li, C. Zhang (Shanghai, China)

Superior cluneal neuralgia in Parkinson’s disease: frequency and clinical features.

M. Mihara, Y. Kajiyama, A. Saito, R. Satake, Y. Kutoku (Kurashiki, Japan)

Supporting Movement Disorders Specialists with Digital Tools that Integrate with their Workflows

J. Ikhile, V. Pandey (Salt Lake City, USA)

Swallowing sound index analysis using electronic stethoscope and artificial intelligence for patients with Parkinson’s disease

R. Matsuyama, M. Nakamori, Y. Shimizu, O. Kikumoto, H. Maruyama (Hiroshima City, Japan)

Temporal Trends in Parkinson’s Disease Related Mortality from 1999-2023: A National Analysis pre and post COVID

N. Bujala, R. Shi, J. Javeid, Z. Xu, F. Yu (New York, USA)

Tendencies of Non-Motor Symptoms and Short-Term Clinical Predictors in Patients with Parkinson’s Disease

R. Nakagawa, M. Shiraishi, N. Takao, H. Matsumoto (Kawasaki City, Kanagawa Prefecture, Japan)

The Cleveland Clinic-Virtual Home Environment (CC-VHE): A Reliable Way to Trigger Freezing of Gait in Parkinson’s disease

A. Rosenfeldt, M. Miller Koop, A. Bazyk, V. Berki, S. Nagel, B. Walter, J. Liao, K. Baker, J. Alberts (Cleveland, USA)

The Complexity of Neuropsychiatric Symptoms Assessment in Parkinson’s Disease: A Rasch Analysis of the Mild Behavioral Impairment-Checklist

Y. Song, L. Ronat, O. Monchi, Z. Ismail, G. Pinilla-Monsalve (Montreal, Canada)

The Effects of Sex and Race on the Quality of Life of Parkinson’s Patients in Hawai’i

R. Shuman, E. Krening, M. Bruno, F. Gao, K. Thai, M. Faouzi, GW. Ross (Hawaii, USA)

The efficacy and safety of continuous subcutaneous infusion therapy with foslevodopa/foscarbidopa

M. Shiraishi, N. Takao, Y. Nakano, Y. Yamano (Kawasaki City, Japan)

The Impact of Depression on Information Storage, Consolidation and Evocation Processes in a Group of Patients Diagnosed with Idiopathic Parkinson’s Disease without Dementia by Deep Brain Stimulation. Descriptive study of the ESDEPARK Scale.

C. Alberto Hurtado-González, J. Felipe Ayala-Rico, S. Ospina-Otalvaro, P. Andrea Gutiérrez-Lenis, A. Lucumi Moreno, M. Cañas-Lucendo, D. Reyes-Torres, L. Villegas-Trujillo, S. Ordoñez-Cure, K. Alejandro Rivera-Quintero (Cali, Colombia)

The Impact of Freezing of Gait on Falls over time in Parkinson’s disease

A. Madamangalam, V. Lavu, J. Yu, Q. Yuan, J. Dwarampudi, J. Wong (Gainesville, USA)

The Impact of Metabolic Syndrome on Parkinson’s Disease Progression: A Systematic Review

T. Denicol, C. Dagostini, MF. Felippe, G. Guindani Maia, G. Dal Alba, J. Sánchez León, A. Hilbig, C. Mello Rieder (Porto Alegre, Brazil)

The Impact of Socioeconomic Status on Functionality in people with Parkinson’s Disease

A. Paixão, N. Pereira, R. Luz, E. Oliveira, I. Chaves, G. Vanucci, M. Piemonte (São Paulo, Brazil)

The influence of Caffeine intake on Type 2 Diabetes Mellitus mediated risk of Parkinson’s Disease.

K. Mallavarapu, E. Tan (Singapore, Singapore)

The Movement Disorders Society Unified Parkinson Disease Rating Scale Motor Subscore Is Not Associated With Future Parkinson Disease Milestones – an observational study using linked health administrative data

P. Gros, S. Bronskill, S. Dorrance, X. Wang, M. Chiu, M. Farkouh, C. Marras (Toronto, Canada)

The Relationship Between Demographic and Clinical Characteristics with Disease Severity and Quality of Life in Parkinson’s Patients

R. Surbakti, A. Angelia, T. Lestarisa, A. Toemon, M. Anugerahny (Palangka Raya, Indonesia)

The relationship between synuclein-related biomarkers and people with upper-respiratory causes of hyposmia or persistent hyposmia

E. Brown, T. Tropea, A. Siderowf, L. Heathers, T. Foroud, C. Gochanour, C. Caspell-Garcia, M. Marshall, R. Kurth, T. Simuni, K. Marek, C. Tanner (San Francisco, USA)

The Role of Cognitive Impairment in the Effectiveness of Rehabilitation Training Programs for Parkinson’s Disease: A Review of Current Evidence

A. Elsayed, Z. Hegazy, K. Ahmed, O. Sabry, S. Elsenbawy, G. Abozeid, M. M. Elsayed (Mansoura, Egypt)

The Role of Knowledgeable Informants in the Early Detection of Parkinson’s Disease

E. Trinh, K. Harrison, M. Korell, C. Meng, E. Brown, K. Comyns, X. Chen, M. Bock, L. Racelo, G. Stebbins, C. Tanner (San Francisco, USA)

The Role of Physiotherapy in Demystifying Parkinson’s Disease and Movement Disorders in Uganda.

S. Nakisanze, J. Mutunzi, E. Jjuuko (Masaka, Uganda)

The Unique Clinical Profile of Dystonia in Parkinson Disease

L. Xavier, A. Eid, H. Hwang, J. Perlmutter, P. Kotzbauer, M. Campbell, S. Norris (Saint Louis, USA)

Trends in U.S. Drug Use Among Hospitalized Parkinson’s Patients Experiencing Delirium

H. Kamo, R. Burke, T. Mehta, M. Remz, M. Okun, C. Hess (Gainesvile, USA)

Turkish Validity and Reliability Study of the Gastrointestinal Dysfunction Scale for Parkinson’s Disease

S. Irmak, H. Omercikoglu, D. Gunal (İstanbul, Turkey)

Unraveling Parkinson’s Disease Heterogeneity: Variability in Dopaminergic Medication Response Over Five Years – A Cluster Analysis of PPMI Data

N. Rajabli, M. Vakhshoori, A. Espay, J. Jones, A. Baghaei, K. Dashtipour (Loma Linda, USA)

Utilization of Healthcare and Deep Brain Stimulation in Black and White Patients with Parkinson’s Disease

M. Padmanaban, C. Liao, J. Johnson, K. Booker, M. Rizig, W. Abou Chaar, J. Bundy, H. Leeper, P. Warnke, B. Chiu, T. Xie (Chicago, USA)

Utilizing the Levodopa Challenge Test to Clarify Clinical Complaints Following Levodopa Administration: A Case Series

M. da Silva, C. Ternes, B. de Lima, R. Mesquita, L. Moriyama (Campinas, Brazil)

Validation of a quantitative test using kinesiological evaluation of upper extremity movements in patients with Parkinson’s disease: A pilot study.

A. Castillo-Ivon, A. Montes-Ugalde, V. Bueyes-Roiz, C. Hernandez-Arenas, P. Velasco-Acosta, L. Anaya-Campos, I. Quiñones-Uriostegui, J. Quinzaños-Fresnedo (Mexico City, Mexico)

What women want: real-life experiences of women with Parkinson’s disease

O. Horbach, D. Dirks, A. Sukar, E. Slow, M. Picillo, V. Bruno (Calgary, Canada)